TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 23 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,764,493 | -30.3% | 2,733,000 | -12.8% | 0.00% | 0.0% |
| Q2 2023 | $2,531,856 | -9.6% | 3,133,000 | +8.7% | 0.00% | 0.0% |
| Q1 2023 | $2,800,114 | +116.5% | 2,883,000 | +102.3% | 0.00% | 0.0% |
| Q4 2022 | $1,293,188 | +462.3% | 1,425,000 | +533.3% | 0.00% | – |
| Q3 2022 | $230,000 | -89.0% | 225,000 | -88.8% | 0.00% | -100.0% |
| Q1 2022 | $2,100,000 | – | 2,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,167 | $17,858 | 1.50% |
| BRAIDWELL LP | 28,350,000 | $27,868,050 | 0.92% |
| READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $8,847,000 | 0.82% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,382,000 | $20,985 | 0.77% |
| UBS OCONNOR LLC | 20,000,000 | $19,700,500 | 0.60% |
| CSS LLC/IL | 8,178,000 | $8,038,680 | 0.53% |
| WOLVERINE ASSET MANAGEMENT LLC | 37,900,000 | $37,317,810 | 0.44% |
| Segantii Capital Management Ltd | 10,000,000 | $9,827,050 | 0.34% |
| LINDEN ADVISORS LP | 28,993,000 | $28,511,354 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,893,000 | $30,367,819 | 0.15% |